Hulting A L, Askensten U, Tribukait B, Wersäll J, Auer G, Grimelius L, Falkmer S, Werner S
Department of Endocrinology, Karolinska Hospital, Stockholm, Sweden.
Acta Endocrinol (Copenh). 1989 Sep;121(3):317-21. doi: 10.1530/acta.0.1210317.
DNA patterns were analysed in 26 GH-producing pituitary adenomas by flow cytometry as well as by microspectrophotometry. Twelve tumours (46%) were diploid according to both methods, whereas 5 tumours (19%) showed aneuploid DNA patterns. Nine tumours were classified differently by the two methods: flow cytometry resulted in diploidy in 2 and aneuploidy in 7 patients, whereas microspectrophotometry showed diploidy in 5 tumours, tetraploidy in 3 and aneuploidy in 1. Methodological limitations may explain the discrepancy in the results obtained by the two methods. However, both the flow cytometry and the microspectrophotometry method show the presence of aneuploid DNA patterns in GH-producing pituitary adenomas despite their benign growth characteristics and the clinically benign course of the disease. This comparative study with two methods measuring DNA content, shows that depending on the criteria used for diploidy-aneuploidy, the frequency of aneuploidy will vary. In this material of 26 GH-producing adenomas, 46% were aneuploid according to flow cytometry and 23% according to microspectrophotometric. However, no correlation to tumour size or GH levels was found with either method when patients with aneuploid and diploid tumours were compared. Therefore, no clinical significance can so far be drawn from these results.
采用流式细胞术和显微分光光度法对26例生长激素分泌型垂体腺瘤的DNA模式进行了分析。根据这两种方法,12例肿瘤(46%)为二倍体,而5例肿瘤(19%)显示非整倍体DNA模式。两种方法对9例肿瘤的分类不同:流式细胞术显示2例患者为二倍体,7例为非整倍体,而显微分光光度法显示5例肿瘤为二倍体,3例为四倍体,1例为非整倍体。方法学上的局限性可能解释了两种方法所得结果的差异。然而,尽管生长激素分泌型垂体腺瘤具有良性生长特征和临床良性病程,但流式细胞术和显微分光光度法均显示存在非整倍体DNA模式。这项使用两种测量DNA含量方法的比较研究表明,根据用于判断二倍体 - 非整倍体的标准不同,非整倍体的频率会有所变化。在这组26例生长激素分泌型腺瘤中,根据流式细胞术46%为非整倍体,根据显微分光光度法为23%。然而,在比较非整倍体和二倍体肿瘤患者时,两种方法均未发现与肿瘤大小或生长激素水平存在相关性。因此,目前这些结果尚无临床意义。